NEW PROGRAM! CHICAGO LUNG CANCER UPDATES 2018advances for the treatment of lung cancer that can be...
Transcript of NEW PROGRAM! CHICAGO LUNG CANCER UPDATES 2018advances for the treatment of lung cancer that can be...
NOVEMB
ER IS
LUNG CANCER AW
AR
EN
ESS MONTH
NOV 16
2018
Register at: https://cme.uchicago.edu/CLCU2018
CONFERENCE CO-DIRECTORSJyoti Patel, MD Everett Vokes, MD
676 North Michigan Avenue Chicago, IL 60611
OMNI HOTEL
CHICAGO LUNG CANCER UPDATES 2018
NEW PROGRAM!
NOV 16
2018
CONFERENCE DESCRIPTION
This educational program will inform clinicians on new therapeutic options and medical advances for the treatment of lung cancer that can be implemented in an effort to reduce lung cancer related deaths. It will provide physicians and other healthcare professionals
with new information that will improve their competence and ultimately improve patient
outcomes. By providing important therapeutic and standard of care developments, this
conference will educate oncologists on best practices for treating the disease.
TARGET AUDIENCEThis activity has been designed for physicians and other healthcare professionals interested in the prevention and treatment of lung cancer.
LEARNING OBJECTIVESAt the conclusion of this education activity, participants will be able to:
• Describe the appropriate selection of diagnostic modalities in the workup of a patient with suspected lung cancer
• Identify how to evaluate patients with malignant airway obstruction, mediastinal/hilar adenopathy, and peripheral lung lesions
• Understand the role of surgical resection for the treatment of locally advanced and oligometastatic lung cancer
• Understand the role of multidisciplinary evaluation of NSCLC patients
• Discuss novel non-invasive strategies for detection of lung cancer
• Understand the relevance of genotyping in NSCLC treatment and identification of targetable oncogenes
• Explain approach to oncogene addicted lung cancers and the role of sequencing targeted approaches
• Report key clinical trial findings on the use of immunotherapeutic strategies in locally advanced and advanced NSCLC
• Understand the role of immunotherapy in advanced NSCLC
• Identify emerging therapies for SCLC
• Understand the state of the art in radiation therapy for NSCLC brain metastases
• Discuss the side effects associated with new chemotherapeutic, targeted, and immunotherapy agents and their management
ACCREDITATION AND CREDIT DESIGNATIONThe University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The University of Chicago Pritzker School of Medicine designates this live activity for a maximum of 7 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Other healthcare professionals will receive a Certificate of Participation. For information on the applicability and acceptance of certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME, please consult your professional licensing board.
LOCATION/ACCOMMODATIONSThe conference will be held at the Omni Chicago Hotel, located at 676 North Michigan Avenue. The only all-suite luxury accommodations on Michigan Avenue are now even better! Embracing the iconic architecture within Chicago, the redesign highlights historical elements of Louis Sullivan’s intricate sketches, the Chicago School’s building materials and the whimsy of modern sculptures synonymous with the city.
We are pleased to offer a special discounted rate for conference attendees. The special rates start at $235.
Reservations for the UChicago Chicago Lung Cancer Updates 2018 conference must be received by the hotel no later than November 1, 2018 to guarantee this special rate.
• Call: 312.266.3014 and ask for Amanda Byrd ([email protected])
CONFERENCE PARKING Parking is available at the Omni Hotel for $27 per car up to 12 hours.
* All rates are subject to state and city taxes. All reservations must be secured via a valid major credit card. Check-in time is 3 pm and check-out time is 12 pm.
The University of Chicago reserves the right to cancel or postpone this conference due to unforeseen circumstances. In the unlikely event this activity must be cancelled or postponed, the registration fee will be refunded; however, The University of Chicago is not responsible for any related costs, charges, or expenses to participants, including fees assessed by airline/travel/lodging agencies.
CONFERENCE FACULTY
Course Directors
University of Chicago Speakers Panel Discussants
Christine Bestvina, MDAssistant Professor (Hematology/Oncology)
Michael Bishop, MDProfessor (Hematology/Oncology)
Steven Chmura, MD, PhD Associate Professor of Radiation and Cellular Oncology
Jessica Donington, MD Professor of Surgery (Thoracic Surgery)
Thomas Hensing, MDClinical Associate Professor (Hematology/Oncology)
Philip Hoffman, MDProfessor of Medicine (Hematology/Oncology)
D. Kyle Hogarth, MDAssociate Professor of Medicine
Pulmonary/Critical Care
Heber MacMahon, MBProfessor of Radiology & Chief, Thoracic Radiology
Lauren L. Ritterhouse, MD, PhDAssistant Professor of Pathology
Co-Director, Division of Genomic & Molecular Pathology
Ralph Weichselbaum, MDD.K. Ludwig Professor of Radiation and Cellular Oncology Chair, Department of Radiation and Cellular Oncology
Brittany Beach, PAPhysician Assistant
Livia Szeto, RNResearch Nurse Associate
Invited Speakers
Hossein Borghaei, DO, MSChief, Division of Thoracic Medical Oncology
Associate Professor, Department of Hematology/Oncology
Fox Chase Cancer Center Temple University
Mary Jo J. Fidler, MDAssociate Professor Medical Oncology Rush Medical Center
Shirish M. Gadgeel, MDMary Lou Kennedy Research Professor in Thoracic Oncology
Professor, Department of Internal Medicine, Division of Hematology/Oncology
University of Michigan
Nisha Mohindra, MDAssistant Professor of Medicine Hematology & Medical Oncology Northwestern University
Jyoti Patel, MDProfessor of Medicine University of Chicago
Director of Thoracic Oncology, University of Chicago Medicine
Everett E. Vokes, MDJohn E. Ultmann Professor
Chairman, Department of Medicine
Physician-in-Chief, University of Chicago Medicine & Biological Sciences
DISCLOSURE DECLARATIONSAs a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine, asks everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. This includes any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The ACCME defines “relevant financial relationships” as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner that could create a conflict of interest. Mechanisms are in place to identify and resolve any potential conflict of interest prior to the start of the activity.
Additionally, The University of Chicago Pritzker School of Medicine, requires Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.
CLI
P H
ER
E T
O M
AIL
IN R
EG
ISTR
ATI
ON
FO
RM
✁
Conference Agenda - 2018CONFERENCE AGENDA
FRIDAY, NOVEMBER 16, 2018
7:00 a.m. PRE-TEST AND REGISTRATION
Session 1: Lung Cancer Immunotherapy, New Challenges/Frontiers
8:00 Welcome and Introductions Jyoti Patel, MD
8:05 First-Line Immunotherapy (Single agent, IO Doublets) Shirish M. Gadgeel, MD
8:30Immunotherapy in Early Stage and Locally Advanced Disease Everett E. Vokes, MD
8:50 Managing irAEs Christine Bestvina, MD
9:05Panel: Crossfire/Clinical Pearls Drs. Vokes, Bestvina, Patel and Gadgeel
9:35 BREAK
Session 2: Advances in Multidisciplinary Care of the Lung Cancer Patient
10:00 Radiology Updates (Nodules, GGOs) Heber MacMahon, MB
10:15 Pulmonary Updates (Peripheral Nodules, EBUS) D. Kyle Hogarth, MD
10:35 Surgery in the Era of Immunotherapy Jessica Donington, MD
11:00 Updates in Radiation Oncology Steven Chmura, MD
11:20 Evolving Role of Molecular Pathologist Lauren L. Ritterhouse, MD, PhD
11:40 Panel/Interactive Cases: All Speakers + Jyoti Patel, MD; Livia Szeto, RN; Brittany Beach, PA
12:10 p.m. LUNCH
Session 3: Mutation-Independent Therapy
1:00 First Line for PDL-1 Negative and Non-Oncogene Addicted Lung Cancer Hossein Borghaei, MD
1:20 Updates on Antiangiogenic Agents Thomas Hensing, MD
1:35 Treatment of Oligometastatic Disease Ralph Weichselbaum, MD
1:55 Advances in SCLC Jyoti Patel, MD
2:15 Panel: How I Treat Panel + Drs. Donington, Chmura and Brittany Beach; Livia Szeto, RN
2:45 BREAK
Session 4: Advances in Molecular-Based Therapy
3:00 Changes in the Landscape of EGFR-TKIs. Front Line and Beyond Christine Bestvina, MD
3:20 Sequencing of ALK Inhibitors Mary Jo Fidler, MD
3:35 BRAF Positive NSCLC Philip Hoffman, MD
3:40 Emerging Targets (ROS1, NTRK, Met, Her2) Nisha Mohindra, MD
3:55 Panel: Challenging Cases in Oncogene Addicted NSCLC Panel + Drs. Ritterhouse and Chmura
Session 5: Cellular Therapies Michael Bishop, MD
4:45 POST-TEST
5:00 ADJOURN
REGISTRATION INFORMATION
Fee
Physicians $150
Trainees and Nurses $30
Payment Total: $
PaymentHow To Register
ONLINE https://cme.uchicago.edu/CLCU2018 (credit card payment only)
To pay by check, you must mail this registration form with payment to:
MAIL The University of Chicago Center for Continuing Medical Education c/o Chicago Lung Cancer Updates 2018
5841 S. Maryland Ave., MC 1137 Chicago, IL 60637
Contact Information
Name Degree
Specialty
Organization
Preferred Mailing Address
City State Zip
Phone Fax
In Case of Emergency
Please indicate any special needs
Please indicate any special dietary needs
Check enclosed (US funds only), payable to The University of Chicago (TID 36-2177139)
You must check this box if you do not want your mailing address shared with conference participants and/or
exhibitors (if applicable).
Please tell us how you found out about this activity, check all that apply:
Colleague Save the Date Brochure Internet Email
Journal Ad Previous Attendance Other
Cancellation PolicyIf you cancel your participation in this conference, your registration fee less a $25 administrative fee will be refunded
when written notification is received by October 15, 2018. No refunds will be made after November 1, 2018.
AccessibilityThe University of Chicago is committed to providing equal access appropriate to need and circumstance and
complies fully with the legal requirements of the Americans with Disabilities Act. If you are in need of special
accommodation, please contact our office at 773-702-1056 or via email at [email protected].
For additional information about this activity, please contact the Center for Continuing Medical Education at
773-702-1056.
CLI
P H
ER
E T
O M
AIL
IN R
EG
ISTR
ATI
ON
FO
RM
✁
The
Uni
vers
ity
of
Chi
cag
oC
ente
r fo
r C
ont
inui
ng M
edic
al E
duc
atio
n 58
41
S. M
aryl
and
Ave
., M
C 1
137
Chi
cag
o, I
L 6
06
37
Fri
day
, Nov
emb
er 1
6, 2
018
| O
mn
i Ho
tel
CH
ICA
GO
LU
NG
CA
NC
ER
U
PD
AT
ES
2018
NO
N-P
RO
FIT
OR
G.
US
PO
STA
GE
PA
IDL
AK
E F
OR
ES
T, IL
PE
RM
IT N
O. 7
9
NE
W P
RO
GR
AM
!
Lear
n ab
out
ne
w t
hera
peu
tic
o
pti
ons
and
m
edic
al
adva
nces
to
re
duc
e lu
ng
canc
er r
elat
ed
dea
ths
NO
VEMBER IS LUNG C
AN
CER
AWARENESS MO
NTH